Latest birth defects Stories
Topamax birth defect claims are being investigated across the country as parents may be unknowingly exposing infants to the anticonvulsant drug in utero, possibly increasing the risk of major birth defects.
As the FDA changes the pregnancy category of migraine drug Topamax to a class D drug, worry over the lack of drug testing for birth defects increases. The Wall Street Journal reports on a history of birth defects related to medications and pregnancy.
The Senators Firm announced today that it is offering free confidential case reviews to people who took Topamax during pregnancy and suffered Topamax induced cleft lip, cleft palate, and oral cleft birth defects.
A new report released Monday by the Natural Resources Defense Council documents 42 "disease clusters" in 13 states, each of which includes incidences of numerous types of cancer, birth defects or other chronic diseases.
Topamax Birth Injury Resources (TBIR) is an online resource center dedicated to providing accurate and up-to-date information about the possible birth defects related to the use of the epilepsy drug Topamax.
The Update on Prenatal Diagnosis and Treatment of Fetal Anomalies conference occurs in Philadelphia today through March 19 Philadelphia, PA (Vocus/PRWEB) March 16, 2011 An international group of over 300 medical experts gathers today to discuss the most current advances in prenatal diagnosis and treatment of birth defects.
PHILADELPHIA, March 16, 2011 /PRNewswire-USNewswire/ -- An international group of over 300 medical experts gathers today to discuss the most current advances in prenatal diagnosis and treatment of birth defects.
The U.S. Food & Drug Administration (FDA) recently issued a safety warning regarding the increased risk of birth defects in babies born to mothers that took Topamax during pregnancy.
FDA strengthens Topamax warning as medication significantly increases oral birth defects, including cleft lip and/or cleft palate, in children whose mothers took Topamax during pregnancy. Fort Lauderdale, FL (PRWEB) March 10, 2011 The Wall Street Journal reports on March 4, 2011 the FDA strengthens Topamax warning as medication significantly increases oral birth defects, including cleft lip and/or cleft palate, in children whose mothers took Topamax during pregnancy.
Thomas J. Henry Injury Attorneys urge mothers who have used Topamax, or its generic topiramate, to contact an attorney as soon as possible if their child was born with any of the following birth defects: cleft lip and/or cleft palate.
- a meat pie that is usually eaten at Christmas in Quebec